Organizing Committee Member
BRIJ M. GANDHI
Neo BioMed Services
At the Department of Biotechnology, Ministry of Science and Technology, Government of India, represented number of International and National bodies and Committees related to International Co operations: Strategic Policy Decisions/Analysis: Biodefence: Biosafety Groups: Research Councils including drug development and environmental sciences etc. Actively involved with number of committees developing national policies on biotechnology including ethical issues for human and animals and development of National Guidelines for Stem Cell Research and Therapy in India and review of policies. Actively associated with the programmes of the Ministry of External Affairs and the Ministry of Home Affairs on Biodefence including Biological Weapons and represented India as an Expert in the U.N. meetings at Geneva on issues related to implementation of protocol for the Biological and Toxin Weapons Convention (BTWC). Coordinated premiere research institutions of DBT including the National Institute of Immunology, New Delhi; National Brain Research Institute, Gurgaon, Haryana; National Centre for Cell Sciences, Pune and the Centre for Diagnostics and Finger Printing, Hyderabad. Also Liaison Officer for the International Centre of Genetic Engineering and Biotechnology (ICGEB), New Delhi component from India; the centre set up by UNDP under the UN System. Presently I am associated with committees and activities of Institute of Defense Research Analysis (IDSA), National Disaster Management Authority (NDMA) and Defense Research Development Organization (DRDO). As CEO and Founder Partner of "NeoBioMed Services", I provide consultancy and services related to complete solutions for import and export of bulk drugs, APIs, other intermediaries and chemicals including the regulatory issues involving government dealings. I help in securing registration of manufacturing plant of Bulk drugs, products and formulations for ultimate Import of the drugs into the country; Grant of test license for drugs, approvals of Protocols for BE / CT and issues of final permissions for Manufacturing & Marketing of Bulk drugs & Formulations, Issue of Import license, Export permission for drugs including locally banned items from Ministry of Health.
Science Management; Research and Development; Policy Matters; Strategic Planning; Management; Administration; Market Strategy; Technology Transfer; Sales and Management; Biodefence Strategies; Institutional Development / Designs related to biotechnology/ regulatory affairs biopharmaceuticals pharmaceuticals/biodefence/healthcare/ life sciences areas including stem cell and regenerative medicine.